- Total operating performance up by 4.3 per cent in the first three quarters
- Equity ratio increases to 30.9 per cent
- Takeover of Farmexim and Help Net in Romania completed
The PHOENIX group achieved further growth in the first nine months of the fiscal year 2018/19 (February to October 2018). Total operating performance increased by 4.3 per cent compared with the same period of the previous year to €24.4 billion. This figure comprises revenue and handling for service charge. Adjusted for foreign exchange rate effects, this corresponds to a rise of 5.2 per cent. The healthcare provider increased its revenue across Europe by €555.8 million (+3.0 per cent) to €19.1 billion. Excluding foreign exchange rate effects, the revenue growth amounted to 3.6 per cent. In particular, this development was connected with revenue gains in Eastern Europe and Germany.
After the first three quarters, the total income of the PHOENIX group stood at €2.0 billion, having increased by €69.2 million in comparison with the same period of the previous year. At €323.6 million, earnings before interest, taxes, depreciation, and amortisation (EBITDA) fell slightly short of the previous year’s figure. This was due to non-recurring effects relating to optimisation programmes. Equity grew from €2.58 billion in the same period of the previous year to €2.72 billion, while the equity ratio rose from 30.1 per cent to 30.9 per cent.
“For the fiscal year 2018/19, we expect our revenue growth to exceed that of the European pharmaceutical markets. With our clear strategy of organic growth and targeted acquisitions, we are continuing to expand our market position in Europe,” said Oliver Windholz, Chief Executive Officer of PHOENIX Pharma SE, on presenting the quarterly figures in Mannheim, Germany.
In the third quarter of 2018/19, the healthcare provider completed the takeover of the Romanian pharmaceutical wholesaler Farmexim S.A. and the nationwide pharmacy chain Help Net Farma S.A. PHOENIX agreed an exclusive partnership with PAYBACK for the German pharmacy market, which will give all German pharmacies access to membership of Germany’s largest loyalty programme. The main focus is digital services for pharmacies and end consumers. PHOENIX plans to connect the PAYBACK benefits with the “deine Apotheke” (“your pharmacy”) PHOENIX app in summer 2019, bringing the company even closer to the end customers.
Key figures of the PHOENIX group compared with the same period of the previous year
| 1st to 3rd quarter 2017/18 in €m | 1st to 3rd quarter 2018/19 in €m | |
| Total operating performance1 | 23.398,7 | 24.408,1 |
| Revenue | 18.496,5 | 19.052,3 |
| Total income2 | 1.962,4 | 2.031,6 |
| EBITDA | 332,7 | 323,6 |
| EBIT | 233,0 | 220,3 |
| Equity3 | 2.584,4 | 2.720,7 |
| Equity ratio (in %)3 | 30,1 | 30,9 |
| Net debt3 | 2.042,1 | 2.096,3 |
(Balance sheet date 31/10/2018)
1 Total operating performance = revenue + handled volume (handling for service charge).
2 Total income = gross income + other operating income.
3 As at reporting dates 31/10/2017 and 31/10/2018.
